436 related articles for article (PubMed ID: 12915655)
1. Improvements in final height over 25 years in growth hormone (GH)-deficient childhood survivors of brain tumors receiving GH replacement.
Gleeson HK; Stoeter R; Ogilvy-Stuart AL; Gattamaneni HR; Brennan BM; Shalet SM
J Clin Endocrinol Metab; 2003 Aug; 88(8):3682-9. PubMed ID: 12915655
[TBL] [Abstract][Full Text] [Related]
2. The effect of administering gonadotropin-releasing hormone agonist with recombinant-human growth hormone (GH) on the final height of girls with isolated GH deficiency: results from a controlled study.
Saggese G; Federico G; Barsanti S; Fiore L
J Clin Endocrinol Metab; 2001 May; 86(5):1900-4. PubMed ID: 11344181
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone therapy alone or in combination with gonadotropin-releasing hormone analog therapy to improve the height deficit in children with congenital adrenal hyperplasia.
Quintos JB; Vogiatzi MG; Harbison MD; New MI
J Clin Endocrinol Metab; 2001 Apr; 86(4):1511-7. PubMed ID: 11297576
[TBL] [Abstract][Full Text] [Related]
4. Reassessment of growth hormone status is required at final height in children treated with growth hormone replacement after radiation therapy.
Gleeson HK; Gattamaneni HR; Smethurst L; Brennan BM; Shalet SM
J Clin Endocrinol Metab; 2004 Feb; 89(2):662-6. PubMed ID: 14764778
[TBL] [Abstract][Full Text] [Related]
5. Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone.
Pasquino AM; Pucarelli I; Roggini M; Segni M
J Clin Endocrinol Metab; 2000 Feb; 85(2):619-22. PubMed ID: 10690865
[TBL] [Abstract][Full Text] [Related]
6. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
Mauras N; Attie KM; Reiter EO; Saenger P; Baptista J
J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
[TBL] [Abstract][Full Text] [Related]
7. Effect on adult height of pubertal growth hormone retesting and withdrawal of therapy in patients with previously diagnosed growth hormone deficiency.
Zucchini S; Pirazzoli P; Baronio F; Gennari M; Bal MO; Balsamo A; Gualandi S; Cicognani A
J Clin Endocrinol Metab; 2006 Nov; 91(11):4271-6. PubMed ID: 16912138
[TBL] [Abstract][Full Text] [Related]
8. Combined treatment with gonadotropin-releasing hormone analog and growth hormone in central precocious puberty.
Pasquino AM; Municchi G; Pucarelli I; Segni M; Mancini MA; Troiani S
J Clin Endocrinol Metab; 1996 Mar; 81(3):948-51. PubMed ID: 8772556
[TBL] [Abstract][Full Text] [Related]
9. Adult final height after GH therapy for irradiation-induced GH deficiency in childhood survivors of brain tumors: the Belgian experience.
Beckers D; Thomas M; Jamart J; Francois I; Maes M; Lebrethon MC; De Waele K; Tenoutasse S; De Schepper J
Eur J Endocrinol; 2010 Mar; 162(3):483-90. PubMed ID: 19969557
[TBL] [Abstract][Full Text] [Related]
10. Final height in growth hormone-deficient childhood cancer survivors after growth hormone therapy.
Rodari G; Cattoni A; Albanese A
J Endocrinol Invest; 2020 Feb; 43(2):209-217. PubMed ID: 31452114
[TBL] [Abstract][Full Text] [Related]
11. Adult height in short children born SGA treated with growth hormone and gonadotropin releasing hormone analog: results of a randomized, dose-response GH trial.
Lem AJ; van der Kaay DC; de Ridder MA; Bakker-van Waarde WM; van der Hulst FJ; Mulder JC; Noordam C; Odink RJ; Oostdijk W; Schroor EJ; Sulkers EJ; Westerlaken C; Hokken-Koelega AC
J Clin Endocrinol Metab; 2012 Nov; 97(11):4096-105. PubMed ID: 22904179
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone therapy in children after cranial/craniospinal radiation therapy: sexually dimorphic outcomes.
Lerner SE; Huang GJ; McMahon D; Sklar CA; Oberfield SE
J Clin Endocrinol Metab; 2004 Dec; 89(12):6100-4. PubMed ID: 15579765
[TBL] [Abstract][Full Text] [Related]
13. A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation.
Kamp GA; Mul D; Waelkens JJ; Jansen M; Delemarre-van de Waal HA; Verhoeven-Wind L; Frölich M; Oostdijk W; Wit JM
J Clin Endocrinol Metab; 2001 Jul; 86(7):2969-75. PubMed ID: 11443153
[TBL] [Abstract][Full Text] [Related]
14. Parentally-adjusted deficit of height as a prognostic factor of the effectiveness of growth hormone (GH) therapy in children with GH deficiency.
Hilczer M; Smyczyńska J; Lewiński A
Neuro Endocrinol Lett; 2006; 27(1-2):149-52. PubMed ID: 16648787
[TBL] [Abstract][Full Text] [Related]
15. Can some growth hormone (GH)-deficient children benefit from combined therapy with gonadotropin-releasing hormone analogs and GH? Results of a retrospective study.
Tauber M; Berro B; Delagnes V; Lounis N; Jouret B; Pienkowski C; Oliver I; Rochiccioli P
J Clin Endocrinol Metab; 2003 Mar; 88(3):1179-83. PubMed ID: 12629103
[TBL] [Abstract][Full Text] [Related]
16. Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone analogues and growth hormone.
Pasquino AM; Pucarelli I; Segni M; Matrunola M; Cerroni F
J Clin Endocrinol Metab; 1999 Feb; 84(2):449-52. PubMed ID: 10022399
[TBL] [Abstract][Full Text] [Related]
17. Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0-3 years) with idiopathic GH Deficiency: analysis of data from KIGS.
Ranke MB; Lindberg A; Albertsson-Wikland K; Wilton P; Price DA; Reiter EO
J Clin Endocrinol Metab; 2005 Apr; 90(4):1966-71. PubMed ID: 15634724
[TBL] [Abstract][Full Text] [Related]
18. Linear growth and final height after treatment for Cushing's disease in childhood.
Lebrethon MC; Grossman AB; Afshar F; Plowman PN; Besser GM; Savage MO
J Clin Endocrinol Metab; 2000 Sep; 85(9):3262-5. PubMed ID: 10999819
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone treatment impact on growth rate and final height of patients who received HSCT with TBI or/and cranial irradiation in childhood: a report from the French Leukaemia Long-Term Follow-Up Study (LEA).
Isfan F; Kanold J; Merlin E; Contet A; Sirvent N; Rochette E; Poiree M; Terral D; Carla-Malpuech H; Reynaud R; Pereira B; Chastagner P; Simeoni MC; Auquier P; Michel G; Deméocq F
Bone Marrow Transplant; 2012 May; 47(5):684-93. PubMed ID: 21725370
[TBL] [Abstract][Full Text] [Related]
20. Combined use of growth hormone and gonadotropin-releasing hormone analogues: the national cooperative growth study experience.
Kohn B; Julius JR; Blethen SL
Pediatrics; 1999 Oct; 104(4 Pt 2):1014-8. PubMed ID: 10506254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
